1. Home
  2. CSTL vs SWBI Comparison

CSTL vs SWBI Comparison

Compare CSTL & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$34.49

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

N/A

Current Price

$14.04

Market Cap

637.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CSTL
SWBI
Founded
2007
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
722.8M
637.4M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
CSTL
SWBI
Price
$34.49
$14.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$45.50
$14.00
AVG Volume (30 Days)
476.5K
380.9K
Earning Date
05-06-2026
06-17-2026
Dividend Yield
N/A
3.37%
EPS Growth
N/A
36.67
EPS
N/A
0.41
Revenue
$344,229,000.00
$523,845,000.00
Revenue This Year
$2.42
$7.61
Revenue Next Year
$12.69
$3.72
P/E Ratio
N/A
$33.93
Revenue Growth
3.66
10.36
52 Week Low
$17.72
$8.01
52 Week High
$44.28
$17.56

Technical Indicators

Market Signals
Indicator
CSTL
SWBI
Relative Strength Index (RSI) 72.19 39.30
Support Level $22.88 $13.64
Resistance Level $41.55 $14.51
Average True Range (ATR) 1.73 0.26
MACD 0.14 -0.03
Stochastic Oscillator 98.98 11.45

Price Performance

Historical Comparison
CSTL
SWBI

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based company engaged in manufacturing and selling firearms. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The company sells its products under the Smith and Wesson and Gemtech brands, which are used for defense, law enforcement, hunting, and sporting purposes. Geographically, it sells products globally, with maximum income being generated by the U.S. market from its handgun products.

Share on Social Networks: